The Public Health and Safety Organization

Free Webinar - Nitrosamine Impurities; What’s the Impact on IMPs

Tuesday, October 6 at 1 p.m. BST

N-nitrosamines are a regulatory and industry hot topic and whilst the focus has been on marketed products rather than development portfolios, there is an impact on investigational medicinal product development and manufacture. Led by expert Paul Cummings, this free NSF webinar introduces the topic of what needs to be considered during development of an IMP, the risks of delaying a formal risk assessment and the potential commercial impact, with the ultimate aim of a safe and efficacious product being granted a marketing authorisation.

Simply fill in your details below to secure your place on this webinar.